Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.5.0.2
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes the number of common shares potentially issuable upon the exercise of certain warrants, convertible notes payable and convertible interest as of September 30, 2016 and September 30, 2015 that have been excluded from the calculation of diluted net loss per common share since the effect would be antidilutive.

 

    September 30, 2016     September 30, 2015  
Warrants -Weighted avg exercise price $4.93     9,506,304       9,556,304  
Convertible notes - Weighted avg conversion price $1.05     3,836,342       1,795,961  
Accrued interest on convertible notes     287,770       60,622  
Total     13,630,416       11,412,887